High-grade hyperinvasive sarcomatoid urothelial bladder carcinoma demonstrating complete response to bladder-preserving chemoradiation

Current Oncology

Volumn 16, Issue 3, 2009, Pages 55-57

  Wallach, Jonathan B ^a   Wang, B ^a   Sanfilippo, N ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bladder carcinoma; Bladder preservation; Chemotherapy; Cystectomy; Quality of life; Radiation oncology; Sarcomatoid carcinoma

Indexed keywords

CISPLATIN; DEXAMETHASONE; PALONOSETRON;

AGED; ARTICLE; BLADDER BIOPSY; BLADDER CARCINOMA; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CASE REPORT; CLINICAL EXAMINATION; CYSTECTOMY; CYSTOSCOPY; FEMALE; HUMAN; HUMAN TISSUE; MULTIPLE CYCLE TREATMENT; SALVAGE THERAPY; UROGENITAL TRACT TUMOR;

EID: 70350610541     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.v16i3.396     Document Type: Article

References (13)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Castelao JE, Yuan JM, Skipper PL, et al. Gender- and smoking-related bladder cancer risk. J Natl Cancer Inst 2001;93:538-545 (Pubitemid 32318433)
3. Borràs J, Borràs JM, Galceran J, Sánchez V, Moreno V, González JR. Trends in smoking-related cancer incidence in Tarragona, Spain, 1980-1996. Cancer Causes Control 2001;12:903-908
4. Miyamoto H, Yang Z, Chen YT, et al. Promotion of bladder cancer development and progression by androgen receptor signals. J Natl Cancer Inst 2007;99:558-568 (Pubitemid 47078733)
5. Dahm P, Gschwend JE. Malignant non-urothelial neoplasms of the urinary bladder: a review. Eur Urol 2003;44:672-681 (Pubitemid 37542925)
6. Manunta A, Vincendeau S, Kiriakou G, Lobel B, Guillé F. Non-transitional cell bladder carcinomas. BJU Int 2005;95:497-502.
7. Lopez-Beltran A, Pacelli A, Rothenberg HJ, et al. Carcinosarcoma and sarcomatoid carcinoma of the bladder: clinicopathological study of 41 cases. J Urol 1998;159:1497-1503 (Pubitemid 29117328)
8. Kachnic LA, Kaufman DS, Heney NM, et al. Bladder preservation by combined modality therapy for invasive bladder cancer. J Clin Oncol 1997;15:1022-1029 (Pubitemid 27106286)
9. Shipley WU, Winter KA, Kaufman DS, et al. Phase iii trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03. J Clin Oncol 1998;16:3576-3583
10. Pansadoro V, Emiliozzi P. Bladder-sparing therapy for muscle-infiltrating bladder cancer. Nat Clin Pract Urol 2008;5:368-375
11. Sauer R, Birkenhake S, Kühn R, Wittekind C, Schrott KM, Martus P. Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer. Int J Radiat Oncol Biol Phys 1998;40:121-127 (Pubitemid 28027576)
12. Froehner M, Gaertner HJ, Manseck A, Wirth MP. Durable complete remission of metastatic sarcomatoid carcinoma of the bladder with cisplatin and gemcitabine in an 80-year-old man. Urology 2001;58:799.
13. Hoshi S, Sasaki M, Muto A, et al. Case of carcinosarcoma of urinary bladder obtained a pathologically complete response by neoadjuvant chemoradiotherapy. Int J Urol 2007;14:79-81. (Pubitemid 44952588)